Champions of Change: DME Advocates Driving Real Change

Published in Government Relations on October 31, 2025

Real change starts with real people. In this edition of Champions of Change, we’re spotlighting two DME advocates who aren’t just talking about problems—they’re taking action. David Griffin and Gary Rench are showing us what it means to stand up for patients, providers, and the future of our industry.

David Griffin Champions Patient Access in the Face of Competitive Bidding Threats 

David Griffin, of Diabetes Specialty Supply in San Antonio, has emerged as a passionate advocate for patients and providers alike in the fight against the inclusion of continuous glucose monitors (CGMs) and other diabetes supplies in the next round of the Medicare Competitive Bidding Program. 

David Griffin
Sen. Ted Cruz's staff member and David Griffin

Deeply concerned about the potentially devastating consequences this change could bring to an already flawed system, David has made it his mission to raise awareness and drive action. He has taken a proactive approach, engaging directly with legislators across multiple states to share firsthand insights into how competitive bidding could disrupt access to essential diabetes care products. 

David’s outreach is not just about policy—it’s about people. David, who is also a CGM user, emphasizes the real-world impact on patients who rely on CGMs and diabetes supplies to manage their health safely and effectively. By highlighting the risks of reduced access, limited supplier participation, and compromised care quality, David is helping lawmakers understand the urgency of the issue. 

His efforts reflect the kind of grassroots advocacy that can make a difference. Through persistent dialogue, education, and collaboration, David is working to ensure that diabetic patients are not left behind in future policy decisions. 

Gary Rench Pushes Back Against Regulatory Overreach in Idaho 

Gary RenchFor the past few years, the National Supplier Clearinghouse (NSC) has been enforcing a position paper that appeared on the Idaho Board of Pharmacy’s website. The context of the paper stated that it was the board’s opinion that a licensed respiratory care practitioner or other qualified licensed healthcare provider must perform the setup and training of oxygen equipment and supplies. 

This interpretation created a major challenge for oxygen suppliers, as NSC began enforcing this opinion as if it were law during supplier enrollment and recertification reviews. As a result, many suppliers were forced to contract with licensed staff solely to meet this perceived requirement. 

Despite strong opposition from suppliers across the state, the NSC’s stance remained unchanged—until recently. 

One Big Sky AMES member, Gary Rench of Sandcreek Medical, refused to give up. Gary remained persistent and worked directly with the Idaho BOP, Idaho Medicaid, and the Idaho Board of Medicine to address the issue. During a recent online meeting, he presented the real-world impact this position paper was having on oxygen suppliers, noting that it could jeopardize his Medicare re-enrollment if not corrected. 

Following that meeting, Gary reached out to the Bureau Chief of the Board of Medicine for an update. She informed him that the board had updated their policy, and it would be posted later that same day. Gary thanked her for the opportunity to speak, and her response was, “It’s nice to have interaction with the regulated community and for the Board and staff to see how their actions impact the real world.” 

Thank you, David and Gary, for your unwavering commitment to strengthening and advancing the DME industry. 

If you're inspired to get more involved and help drive meaningful change, feel free to reach out at emily.kettman@vgm.com for assistance. 

From Our Experts

CMS Releases CPI-U Adjustments for DMEPOS In 2026 And Fee Schedule Q1 thumbnail CMS Releases CPI-U Adjustments for DMEPOS In 2026 And Fee Schedule Q1 The Centers for Medicare & Medicaid Services (CMS) released the annual inflation factor to be applied to DMEPOS items effective January 1, 2026, with an implementation date of January 5, 2026. The breakdown of the adjustment is dependent upon whether the serviced items are included in the competitive bidding program (CBP) or are in formerly competitive bid areas (CBAs) such as rural and non-rural. Update from the Board of Certification/Accreditation thumbnail Update from the Board of Certification/Accreditation Yesterday, the Board of Certification/Accreditation (BOC) issued a clarification regarding the Centers for Medicare & Medicaid's (CMS) recent announcement about withdrawing BOC Accreditation. Here are the key updates... CMS Withdraws BOC Accreditation Authority For DMEPOS Suppliers thumbnail CMS Withdraws BOC Accreditation Authority For DMEPOS Suppliers On December 2, 2025, the Centers for Medicare & Medicaid Services (CMS) officially revoked the Board of Certification/Accreditation International (BOC) as an approved accreditation organization for suppliers of durable medical equipment, prosthetics, orthotics, and supplies (DMEPOS). The DMEPOS Competitive Bid Program (CBP) And The New Remote Item Delivery Competitive Bidding Program – What Suppliers Need To Know thumbnail The DMEPOS Competitive Bid Program (CBP) And The New Remote Item Delivery Competitive Bidding Program – What Suppliers Need To Know A major development to come out of the CMS DMEPOS/Home Health Final Rule is the creation of a new Remote Item Delivery (RID) competitive bid program (CBP). This article provides the key items DMEPOS suppliers need to be aware of regarding this significant development in the competitive bidding program. CMS Changes Accreditation Requirements For All DMEPOS Suppliers Effective January 1, 2026. thumbnail CMS Changes Accreditation Requirements For All DMEPOS Suppliers Effective January 1, 2026. As we shared last week, CMS finalized the DMEPOS accreditation rule change that requires Accrediting Organizations (AOs) to survey and recredential DMEPOS suppliers annually, instead of every three years. This change is outside of competitive bidding and applies to all DMEPOS suppliers as a condition of Medicare enrollment. FAQs from the Webinar: Understanding the Final Rule on the DMEPOS Competitive Bidding Program thumbnail FAQs from the Webinar: Understanding the Final Rule on the DMEPOS Competitive Bidding Program Thank you to everyone who joined last week's webinar! We've compiled the most frequently asked questions from the session along with updated answers to help you stay informed. Major Update On Product Categories For The Next Round Of Competitive Bidding thumbnail Major Update On Product Categories For The Next Round Of Competitive Bidding Since the publication of the Final Rules on the Competitive Bidding Program (CBP) was announced, VGM has been in conversation with CMS officials as well as other industry groups regarding additional products being included into the CBP. The unofficial feedback we received indicated that there would be no additional products beyond those reported in the Final Rule. CMS Finalizes Rule Changing The Next Round Of The Competitive Bidding Program And Updating Other Provisions Related To Provider Enrollment And Prior Authorization thumbnail CMS Finalizes Rule Changing The Next Round Of The Competitive Bidding Program And Updating Other Provisions Related To Provider Enrollment And Prior Authorization Final Rule Analysis from the VGM Payer Relations and Reimbursement team  On Nov, 28, 2025, CMS finalized Final Rule CMS-1828-F that includes updates to the Competitive Bidding Program (CBP) and other provisions related to provider enrollment and prior authorization. Next round is expected to be implemented no later than Jan. 1, 2028.